Welcome to our dedicated page for Rocket One SEC filings (Ticker: RKTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Rocket One's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Rocket One's regulatory disclosures and financial reporting.
Rocket One Inc. is expanding its AI infrastructure strategy through a strategic collaboration with Placeve Inc., which includes an initial investment and joint evaluation of Placeve’s AI processor architecture, software platform and machine‑learning technologies for defense, space and intelligent edge computing. Placeve’s photonic‑electronic AI processor technology is being evaluated through NASA’s Materials International Space Station Experiment (MISSE) program aboard the International Space Station.
Rocket One also prepared investor presentation materials outlining three core platforms: a nanomagnetic matrix multiplier compute‑in‑memory accelerator targeting ~5 ns, ~500 aJ multiply‑and‑accumulate operations; skyrmion‑mediated spintronic memory switching in ~1 ns at 100–1,000× lower energy than commercial STT‑MRAM with intrinsic radiation tolerance; and the Swarm Stage AI autonomous swarm defense and training platform with over 2,500 field‑tested formations. Together with its existing biotechnology programs held in a subsidiary, these initiatives support an integrated AI and space‑oriented infrastructure strategy.
Rocket One Inc. has regained full compliance with Nasdaq’s minimum bid price requirement for its RKTO common stock. Nasdaq notified the company that, for the ten consecutive business days from June 9 through June 23, 2026, Rocket One’s closing bid price stayed at or above $1.00 per share, satisfying Listing Rule 5550(a)(2). As a result, the company’s continued listing on The Nasdaq Capital Market is no longer at risk from this issue. Management links this milestone to its ongoing strategic shift from biotechnology to advanced AI computing, defense infrastructure, and space-enabling technologies.
Rocket One Inc., formerly Hoth Therapeutics, has amended its Nevada charter to change its corporate name to Rocket One Inc. effective May 26, 2026. The company’s common stock will begin trading on The Nasdaq Capital Market under the new ticker “RKTO” on May 28, 2026, replacing “HOTH.”
The company is repositioning around the “orbital economy,” focusing on next-generation nanomagnetic AI chip technology designed for ultra-low-power, radiation-tolerant computing in space and defense applications. Its legacy biotechnology programs will continue under a wholly owned subsidiary, now named Rocket One.0 Inc. Shareholder rights and the CUSIP for the common stock remain unchanged.